FOXO4-DRI (FOXO4-DRI peptide inhibitor) is a synthetic peptide fragment designed to interfere with the interaction between the FOXO4 protein and p53. By disrupting this binding, FOXO4-DRI allows senescent (damaged or “aged”) cells to undergo apoptosis while leaving healthy cells intact.
This selective mechanism has made FOXO4-DRI a promising focus of research in the fields of senolytics, longevity, and regenerative medicine.
Potential areas of research include:
-
Selective clearance of senescent cells
-
Studies in anti-aging and cellular rejuvenation
-
Support for tissue regeneration and repair
-
Exploration of neuroprotective effects
-
Improved vitality and healthspan in longevity research
FOXO4-DRI represents one of the most advanced investigational compounds in the pursuit of healthy aging and senolytic therapy development.
Disclaimer: For Research Use Only – Not for Human Use.




